Anti-ALG9 polyclonal antibody

Antibody Isotype

IgG

Species Reactivity

Human

Immunogen

Recombinant protein corresponding to amino acids of human ALG9.

Conjugate

Application Notes

IHC: 1:50-1:200
WB: 1:250-1:500

Alternative Names

ALG9; asparagine-linked glycosylation 9, alpha-1, 2-mannosyltransferase homolog (S. cerevisiae); asparagine linked glycosylation 9 homolog (yeast, alpha 1, 2 mannosyltransferase) , asparagine linked glycosylation 9, alpha 1, 2 mannosyltransferase homolog (S. cerevisiae, alpha 1, 2 mannosyltransferase) , DIBD1, disrupted in bipolar affective disorder 1; alpha-1, 2-mannosyltransferase ALG9; disrupted in bipolar disorder protein 1; disrupted in bipolar affective disorder 1; asparagine-linked glycosylation protein 9 homolog; dol-P-Man:ManGlcNAc-PP-Dol alpha-1, 2-mannosyltransferase; dol-P-Man:ManGlcNAc-PP-Dol alpha-1, 2-mannosyltransferase; loss of heterozygosity, 11, chromosomal region2gene J product; asparagine-linked glycosylation 9 homolog (yeast, alpha- 1, 2-mannosyltransferase); asparagine-linked glycosylation 9 homolog (S. cerevisiae, alpha- 1, 2-mannosyltransferase); CDG1L; DIBD1; LOH11CR1J; FLJ21845; DKFZp586M2420;

Entrez Gene ID

UniProt ID

Pathway

Asparagine N-linked glycosylation, organism-specific biosystem; Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein, organism-specific biosystem; Metabolic pathways, organism-specific biosystem; Metabolism of proteins, organism-specific biosystem; N-Glycan biosynthesis, organism-specific biosystem; N-Glycan biosynthesis, conserved biosystem; N-glycan precursor biosynthesis, organism-specific biosystem;